1. Topalian SL, Rosenberg SA. Adoptive cellular therapy: basic principles. In: DeVita VT Jr, Hellman S, Rosenberg SA, editors. Biologic therapy of cancer. Philadelphia: Lippincott; 1991. p. 187. [Google Scholar]
2. Hurlimann J, Saraga P. Mononuclear cells infiltrating human mammary carcinomas: immunohistochemical analysis with monoclonal antibodies. Int J Cancer. 1985;35:753. [PubMed] [Google Scholar]
3. Whiteside TL, Miescher S, Hurlimann J, Moretta L, Von Fliedner V. Clonal analysis and in situ characterization of lymphocytes infiltrating human breast carcinomas. Cancer Immunol Immunother. 1986;23:169. [PMC free article] [PubMed] [Google Scholar]
4. Ferguson A, Moore M, Fox H. Expression of MHC products and leucocyte differentiation antigens in gynaecological neoplasms: an immunohistological analysis of the tumour cells and infiltrating leucocytes. Br J Cancer. 1985;52:551. [PMC free article] [PubMed] [Google Scholar]
5. Wolf GT, Hudson JL, Peterson KA, Miller HL, McClatchey KD. Lymphocyte subpopulations infiltrating squamous carcinomas of the head and neck: correlations with extent of tumor and prognosis. Otolaryngol Head Neck Surg. 1986;95:142. [PubMed] [Google Scholar]
6. Schoorl R, de la Rivière Brutel A, von dem Borne AEGKr, Feltkamp-Vroom TM. Identification of T and B lymphocytes in human breast cancer with immunohistochemical techniques. Am J Pathol. 1976;84:529. [PMC free article] [PubMed] [Google Scholar]
7. Husby G, Hoagland PM, Strickland RG, Williams RC. Tissue T and B cell infiltration of primary and metastatic cancer. J Clin Invest. 1976;57:1471. [PMC free article] [PubMed] [Google Scholar]
8. Stevens A, Klöter I, Roggendorf W. Inflammatory infiltrates and natural killer cell presence in human brain tumors. Cancer. 1988;61:738. [PubMed] [Google Scholar]
9. Vose BM, Moore M. Suppressor cell activity of lymphocytes infiltrating human lung and breast tumours. Int J Cancer. 1979;24:579. [PubMed] [Google Scholar]
10. Bröcker EB, Zwadlo G, Holzmann B, Macher E, Sorg C. Inflammatory cell infiltrates in human melanoma at different stages of tumor progression. Int J Cancer. 1988;41:562. [PubMed] [Google Scholar]
11. Withford P, Mallon EA, George WD, Campbell AM. Flow cytometric analysis of tumor infiltrating lymphocytes in breast cancer. Br J Cancer. 1990;62:971. [PMC free article] [PubMed] [Google Scholar]
12. Sikora K, Alderson T, Philips J, Watson JV. Human hybridomas from malignant gliomas. Lancet. 1982;1:11. [PubMed] [Google Scholar]
13. Sikora K, Alderson T, Ellis J, Philips J, Watson J. Human hybridomas from patients with malignant diseases. Br J Cancer. 1983;47:135. [PMC free article] [PubMed] [Google Scholar]
14. Jerne NK, Henry C, Nordin AA, et al. Plaque forming cells: methodology and theory. Transplant Rev. 1974;18:130. [PubMed] [Google Scholar]
15. Henderson E, Miller G, Robinson J, Heston L. Efficiency of transformation of lymphocytes by Epstein-Barr virus. Virology. 1977;76:152. [PubMed] [Google Scholar]
16. Aman P, Ehlin-Henriksson B, Klein G. Epstein-Barr virus susceptibility of normal human B lymphocyte populations. J Exp Med. 1984;159:208. [PMC free article] [PubMed] [Google Scholar]
17. Kozbor D, Croce CH. Fusion partners for production of human monoclonal antibodies. In: Engleman EG, Foung SKH, Larrick J, Raubitschek A, editors. Human hybridomas and monoclonal antibodies. New York: Plenum; 1985. p. 21. [Google Scholar]
18. Hirohata S, Jelinek DF, Lipsky PE. T cell-dependent activation and differentiation of B cell proliferation by immobilized monoclonal antibodies to CD3. J Immunol. 1988;140:3736. [PubMed] [Google Scholar]
19. Amoroso K, Lipsky PE. Frequency of human B cells that differentiate in response to anti-CD3-activated T cells. J Immunol. 1990;145:3155. [PubMed] [Google Scholar]
20. Kelly PJ, Pascual V, Capra JD, Lipsky PE. Anti-CD3-stimulated T cells induce the production of multiple Ig H chain isotypes by individual human peripheral B lymphocytes. J Immunol. 1992;148:1294. [PubMed] [Google Scholar]
21. Barbuto JAM, Verastegui EL, Hersh EM. The use of transformed T cell lines for clonal expansion of human B cells from peripheral blood, spleen, and tumor-infiltrating lymphocytes. Hybridoma. 1993;12:115. [PubMed] [Google Scholar]
22. Hersh EM, Mavligit GM, Gutterman JU. Immunodeficiency in cancer and the importance of immune evaluation of the cancer patient. Med Clin N Am. 1976;60:623. [PubMed] [Google Scholar]
23. Miescher S, Whiteside TL, Carrel S, Von Fliedner V. Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferative responses of lymphocytes. J Immunol. 1986;136:1899. [PubMed] [Google Scholar]
24. Lane HC, Fauci AS. Immunologic abnormalities in the acquired immunodeficiency syndrome. Annu Rev Immunol. 1985;3:477. [PubMed] [Google Scholar]
25. Saxon A, Feldhaus J, Robins RA. Single step separation of human T and B cells using AET treated sheep red cells. J Immunol Methods. 1976;90:221. [PubMed] [Google Scholar]
26. Thiele DL, Kurosaka M, Lipsky PE. Phenotype of the accessory cell necessary for mitogen-stimulated T and B cell responses in human peripheral blood: delineation by its sensitivity to the lysomotropic agent,l-leucine methyl ester. J. Immunol. 1983;131:2282. [PubMed] [Google Scholar]
27. Bishop GA, Hwang J. Use of a cellular ELISA for the detection of cell surface antigens. Biotechniques. 1992;12:326. [PubMed] [Google Scholar]
28. Henry C, Marbrook J, Vann DC, Kondlin D, Wofsy C. Limiting dilution analysis. In: Mishell BB, Shiigi SM, editors. Selected methods in cellular immunology. San Francisco: Freeman; 1980. p. 138. [Google Scholar]
29. Chandler HM, Cox JC, Healy K, MacGregor A, Premier RR, Hurrell JGR. An investigation of the use of urease-antibody conjugates in enzyme immunoassays. J Immunol Methods. 1982;53:187. [PubMed] [Google Scholar]
30. Douillard JY, Hoffman T, Herberman RB. Enzyme-linked immunosorbent assay for screening monoclonal antibody production: use of intact cells as antigen. J Immunol Methods. 1980;39:309. [PubMed] [Google Scholar]
31. Suter L, Bruggen J, Sorg C. Use of an enzyme-linked immunosorbent assay (ELISA) for screening of hybridoma antibodies against cell surface antigens. J Immunol Methods. 1980;39:407. [PubMed] [Google Scholar]
32. Hellström KE, Hellström I. Principles of tumor immunity: tumor antigens. In: DeVita VT Jr, Hellman S, Rosenberg SA, editors. Biologic therapy of cancer. Philadelphia: Lippincott; 1991. p. 42. [Google Scholar]
33. Kawakami Y, Zakut R, Topalian SL, Stötter H, Rosenberg SA. Shared human melanoma antigens. Recognition by tumor-infiltrating lymphocytes in HLA-A2.1-transfected melanomas. J Immunol. 1992;148:638. [PubMed] [Google Scholar]
34. Sjögren HD, Hellström I, Bansal SC, Warner GA, Hellström KE. Elution of “blocking factors” from human tumors, capable of abrogating tumor-cell destruction by specific immune lymphocytes. Int J Cancer. 1972;9:274. [PubMed] [Google Scholar]
35. Manson LA. Does antibody-dependent epitope masking permit progressive tumour growth in the face of cell-mediated cytotoxicity? Immunol Today. 1991;12:352. [PubMed] [Google Scholar]
